GMFG
Glia maturation factor gamma
Also known as: GMFG_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O60234
- Gene
- GMFG
- Ensembl
- ENSG00000130755
- Chromosome
- 19
- Canonical length
- 142 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies,Cytosol
OverviewNCBI Gene
Predicted to enable Arp2/3 complex binding activity. Predicted to be involved in actin filament debranching and negative regulation of Arp2/3 complex-mediated actin nucleation. Predicted to be located in extracellular region; ficolin-1-rich granule lumen; and secretory granule lumen. Predicted to be active in cortical actin cytoskeleton. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
142 residues, UniProt reviewed canonical sequence.
>O60234|GMFG
1 MSDSLVVCEV DPELTEKLRK FRFRKETDNA AIIMKVDKDR QMVVLEEEFQ NISPEELKME
61 LPERQPRFVV YSYKYVHDDG RVSYPLCFIF SSPVGCKPEQ QMMYAGSKNR LVQTAELTKV
121 FEIRTTDDLT EAWLQEKLSF FRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GMFG can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 545 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 545 nTPM
- thymus: 429 nTPM
- spleen: 364 nTPM
- lymph node: 280 nTPM
- tonsil: 246 nTPM
- appendix: 178 nTPM
Single-cell type
- neutrophils: 1,712 nCPM
- megakaryocytes: 909 nCPM
- hofbauer cells: 742 nCPM
- neutrophil progenitors: 534 nCPM
- monocytes: 457 nCPM
- platelets: 454 nCPM
Immune cell
- neutrophil: 5,299 nTPM
- basophil: 4,411 nTPM
- eosinophil: 3,635 nTPM
- total PBMC: 2,622 nTPM
- T-reg: 1,846 nTPM
- non-classical monocyte: 1,695 nTPM
Brain region
- white matter: 25 nTPM
- medulla oblongata: 22 nTPM
- cerebral cortex: 20 nTPM
- pons: 20 nTPM
- choroid plexus: 18 nTPM
- spinal cord: 18 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.64
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.18
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin filament debranching
- negative regulation of Arp2/3 complex-mediated actin nucleation
- protein phosphorylation
Molecular functions
- actin binding
- Arp2/3 complex binding
- enzyme activator activity
- growth factor activity
- protein kinase inhibitor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GMFG as an antibody target. Whether an autoantibody or antibody against GMFG could matter depends on whether native GMFG is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GMFG is annotated as secreted, so native GMFG circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label GMFG as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...